Virpax Pharmaceuticals Inc.
13F holders, Q1 2024 (March 31)1holders
$4.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Virpax Pharmaceuticals Inc. in their 13F filings. The largest holder was Parallel Advisors, LLC ($4).
- Company
- Virpax Pharmaceuticals Inc.
- CUSIP
- 928251107
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 18 | $121K |
Ownership 1 holders
| Parallel Advisors, LLC | 0.00% | Reduce -92.9% | 1 | $4 |
"% of holder's portfolio" is VIRPAX PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Virpax Pharmaceuticals Inc. the manager owns.